BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16998294)

  • 1. [Reappraisal of risk factors predicting liver complications from radiotherapy for hepatocellular carcinoma].
    Lee IJ; Seong J; Shim SJ; Han KH; Chon CY
    Korean J Hepatol; 2006 Sep; 12(3):420-8. PubMed ID: 16998294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
    Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
    Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal complications after radiation therapy in patients with hepatocellular carcinoma.
    Yang MH; Lee JH; Choi MS; Park HS; Rhee PL; Kim JJ; Paik SW; Rhee JC; Lim DH
    Hepatogastroenterology; 2005; 52(66):1759-63. PubMed ID: 16334773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial.
    Mornex F; Girard N; Beziat C; Kubas A; Khodri M; Trepo C; Merle P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1152-8. PubMed ID: 17145534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy.
    Lee IJ; Seong J; Shim SJ; Han KH
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):154-8. PubMed ID: 18823715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.
    Kawashima M; Furuse J; Nishio T; Konishi M; Ishii H; Kinoshita T; Nagase M; Nihei K; Ogino T
    J Clin Oncol; 2005 Mar; 23(9):1839-46. PubMed ID: 15774777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial].
    Mornex F; Girard N; Merle P; Béziat C; Kubas A; Wautot V; Khodri M; Trepo C
    Cancer Radiother; 2005 Nov; 9(6-7):470-6. PubMed ID: 16219480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor size and operative risks of extended right-sided hepatic resection for hepatocellular carcinoma: implication for preoperative portal vein embolization.
    Chik BH; Liu CL; Fan ST; Lo CM; Poon RT; Lam CM; Wong J
    Arch Surg; 2007 Jan; 142(1):63-9; discussion 69. PubMed ID: 17224502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis.
    Kato H; Tsujii H; Miyamoto T; Mizoe JE; Kamada T; Tsuji H; Yamada S; Kandatsu S; Yoshikawa K; Obata T; Ezawa H; Morita S; Tomizawa M; Morimoto N; Fujita J; Ohto M;
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1468-76. PubMed ID: 15275734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
    Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
    Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival.
    Zhang XF; Meng B; Qi X; Yu L; Liu C; Liu XM; Wang B; Pan CE; Lv Y
    Eur J Surg Oncol; 2009 Jun; 35(6):622-8. PubMed ID: 18835514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization.
    Zhang XB; Wang JH; Yan ZP; Qian S; Du SS; Zeng ZC
    Cancer; 2009 Mar; 115(6):1245-52. PubMed ID: 19156918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial volume tolerance of the liver to radiation.
    Dawson LA; Ten Haken RK
    Semin Radiat Oncol; 2005 Oct; 15(4):279-83. PubMed ID: 16183482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
    Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
    J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.